3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
25
Squamous Cell Carcinoma of Head and Neck
10
Lung Neoplasms
10
Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
5
Breast Neoplasms
5
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Stomach Neoplasms
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Prostatic Neoplasms
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
NSCLC
2
Glioblastoma
2
Colorectal Neoplasms
2
Adenocarcinoma of Lung
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unilateral HER2 Positive Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thrombocytosis
1
Thoracic Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Interventions
Cisplatin
17
Radiotherapy
11
Cetuximab
11
Surveys and Questionnaires
10
pembrolizumab
9
Biopsy
9
Radiation
8
Magnetic Resonance Spectroscopy
8
Drug Therapy
8
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
7
Carboplatin
7
X-Rays
6
Specimen Handling
6
Fluorouracil
6
Celecoxib
6
Standard of Care
5
Paclitaxel
5
Observation
5
Sentinel Lymph Node Biopsy
4
Interviews as Topic
4
Chemoradiotherapy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Watchful Waiting
3
Ultrasonography
3
Taxes
3
Practice Guidelines as Topic
3
Positron Emission Tomography Computed Tomography
3
Platinum
3
Optical Imaging
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mouth Neoplasms
×
Afatinib
×
Clear all
NCT06897735
2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1
Terminated
4 enrolled